|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| OPERATING EXPENSES | ||
| Research and development | ||
| General and administrative | ||
| Loss from operations | ||
| OTHER INCOME/EXPENSE | ||
| Interest income | ||
| Interest expense | ||
| Non-operating income | ||
| Non-operating expenses | ||
| Change in fair value of warrant liability | ||
| TOTAL OTHER INCOME/EXPENSE | ||
| NET LOSS | ||
| Cumulative Series A preferred stock dividend requirement | ||
| NET LOSS available to common shareholders | ||
| Weighted average # of shares (in Shares) | ||
| Basic loss per common share outstanding (in Dollars per share) | ||
| Diluted loss per common share outstanding (in Dollars per share) |
Loading...
